Budget Impact Analysis of Everolimus for the Treatment of Hormone Receptor Positive, Human Epidermal Growth Factor Receptor-2 Negative (HER2-) Advanced Breast Cancer in Kazakhstan
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2202
https://www.valueinhealthjournal.com/article/S1098-3015(14)04132-1/fulltext
Title :
Budget Impact Analysis of Everolimus for the Treatment of Hormone Receptor Positive, Human Epidermal Growth Factor Receptor-2 Negative (HER2-) Advanced Breast Cancer in Kazakhstan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04132-1&doi=10.1016/j.jval.2014.08.2202
First page :
A621
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1660